“Once-Daily Roflumilast Cream 0.3%, a Potent Phosphodiesterase-4 Inhibitor, Provided Safe and Effective Treatment of Psoriasis in the DERMIS-1 and DERMIS-2 Phase 3 Trials”. 2021. SKIN The Journal of Cutaneous Medicine 5 (6): s42. https://doi.org/10.25251/skin.5.supp.42.